Previous close | 13.75 |
Open | 13.83 |
Bid | 13.80 x 800 |
Ask | 13.80 x 800 |
Day's range | 13.58 - 14.04 |
52-week range | 12.06 - 41.50 |
Volume | |
Avg. volume | 822,139 |
Market cap | 683.491M |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | 81.35 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.24 (1.74%) |
Ex-dividend date | 23 Feb 2024 |
1y target est | N/A |
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*
PROVO, Utah, February 14, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance.
PROVO, Utah, January 08, 2024--Nu Skin execs are scheduled to present at ICR Conference. The company also shared Q4 preliminary revenue with full results to be reported Feb. 14.